- Latest week
- 17 Jul 2026
- Close
- 157.240000
- Fair value
- 67.824518
- Next-week expectancy
- Positive 58.57%
PVLA Chart Pack
Palvella Therapeutics, Inc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, PVLA rose 23.97%, moving from 126.84 to 157.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 49.94 and has softened across the 12-week window. Market Dynamics is 0.65 on the latest week. Next-week expectancy is positive at 58.57% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 157.24
- 12-Week Change
- 23.97%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 58.57%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 49.94
- Market Dynamics
- 0.65
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 157.24
- 12-Week Change
- 23.97%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 58.57%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 49.94
- Market Dynamics
- 0.65
Over the latest 12 completed weeks ending 2026-07-17, PVLA rose 23.97%, moving from 126.84 to 157.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 49.94 and has softened across the 12-week window. Market Dynamics is 0.65 on the latest week. Next-week expectancy is positive at 58.57% based on similar historical setup states.
Industry Peers
United States equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| NXTC NextCure Inc | NASDAQ | 17 Jul 2026 | 2.00 | 9.90 | 1.70 | 5.99 | 199.50% |
| JSPR Jasper Therapeutics Inc | NASDAQ | 17 Jul 2026 | 0.60 | 1.03 | 0.58 | 0.89 | 47.50% |
| OSRH OSR Holdings Inc | NASDAQ | 17 Jul 2026 | 0.33 | 0.51 | 0.33 | 0.47 | 43.18% |
| ATAI ATAI Life Sciences BV | NASDAQ | 17 Jul 2026 | 5.10 | 7.22 | 4.81 | 7.22 | 41.57% |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | NASDAQ | 17 Jul 2026 | 38.39 | 50.11 | 37.99 | 49.29 | 28.39% |
| EVGN Evogene | NASDAQ | 17 Jul 2026 | 0.50 | 0.68 | 0.44 | 0.63 | 25.80% |
| MRVI Maravai Lifesciences Holdings Inc | NASDAQ | 17 Jul 2026 | 6.00 | 7.26 | 6.00 | 7.24 | 20.63% |
| IOVA Iovance Biotherapeutics Inc | NASDAQ | 17 Jul 2026 | 4.16 | 5.13 | 3.76 | 5.00 | 20.19% |
| ENTX Entera Bio Ltd | NASDAQ | 17 Jul 2026 | 1.65 | 2.09 | 1.57 | 1.98 | 20.00% |
| VYNE Vyne Therapeutics Inc | NASDAQ | 17 Jul 2026 | 0.64 | 0.79 | 0.64 | 0.76 | 19.84% |
| DYAI Dyadic International Inc | NASDAQ | 17 Jul 2026 | 1.06 | 1.34 | 0.98 | 1.26 | 18.87% |
| ANL Adlai Nortye Ltd. American Depositary Shares | NASDAQ | 17 Jul 2026 | 9.80 | 11.90 | 8.88 | 11.53 | 17.65% |
| BOLT Bolt Biotherapeutics | NASDAQ | 17 Jul 2026 | 3.78 | 4.42 | 3.78 | 4.42 | 16.93% |
| SLN Silence Therapeutics PLC | NASDAQ | 17 Jul 2026 | 8.98 | 11.19 | 8.91 | 10.50 | 16.93% |
| ACTU Actuate Therapeutics, Inc. Common stock | NASDAQ | 17 Jul 2026 | 1.25 | 1.95 | 1.25 | 1.44 | 15.20% |
| HRTX Heron Therapeuti | NASDAQ | 17 Jul 2026 | 0.41 | 0.50 | 0.39 | 0.47 | 14.80% |